Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 3/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 1||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Dizziness, Fatigue, Menstrual disorder, Nausea
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days:
Write-up:Information has been received from Sanofi Pasteur MSD (reference # IE-1577272925-2016001591) on 23-FEB-2016. This case was received from the health authority on 19-Feb-2016. Ref IE-HPRA-2016-025943. Initial report was received by the RA on 04/Feb/2016 from a member of the public (patient''s mother) which concerns a 13 year old female patient who experienced Dizziness, Nausea, Fatigue and Menstrual disorder following vaccination with GARDASIL (batch/lot # and expiration date not reported). Concomitant medications: None. Medical history/concurrent conditions: None reported. The patient was vaccinated with GARDASIL on 23/Sep/2011 and 21/Mar/2012. Post vaccination, the patient experienced dizziness, nausea, tiredness and menstrual problems that are ongoing to date. Corrective treatment: None reported.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166